Company / Current Liabilities
PTC Therapeutics, Inc. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$968.4M
FY2025
5-year range
$406.2M / $968.4M
FY2021-FY2025
Trend
+66.7%
vs FY2024
Sector context
#25 of 213
Health Care
What the data says
PTC Therapeutics, Inc.'s current liabilities of $968M is higher than 88% of companies in the Health Care sector (FY2025). Current Liabilities has fluctuated over the past 10 years, ranging from $50M in FY2016 to $968M in FY2025.
Based on SEC 10-K filings.
$968M in FY2025 with a 5-year CAGR of +28.4%. Top quartile in the Health Care sector.
Increased from $603M to $968M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +33.6%
- 5-Year CAGR
- +28.4%
- 10-Year CAGR
- -
Sector benchmark
-39.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +28.4%, indicating consistent growth.
- In FY2025, current liabilities increased 66.7% year-over-year.
- Ranks #25 out of 213 companies in the Health Care sector.
- Lowest current liabilities in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $968.4M | +66.7% |
| FY2024 | $581.0M | -3.7% |
| FY2023 | $603.1M | +48.5% |
| FY2022 | $406.2M | -20.2% |
| FY2021 | $509.3M | +83.7% |
| FY2020 | $277.3M | +17.6% |
| FY2019 | $235.9M | +41.4% |
| FY2018 | $166.8M | +103.3% |
| FY2017 | $82.0M | +65.3% |
| FY2016 | $49.6M | +9.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026